Recently, sequencing of whole exomes from patients with sporadic or familial focal and segmental glomerulosclerosis (FSGS) identified three new genes (SCAF1, SETD2, and LY9) that are located closer to known FSGS genes. This evidence concerns the gene SETD2 and focal segmental glomerulosclerosis.